there is a role for biomarkers/genomics in the risk stratification of prostate cancer
Published 5 years ago • 115 plays • Length 10:04Download video MP4
Download video MP3
Similar videos
-
8:53
pro: the role of currently available biomarkers genomics in risk stratification of prostate cancer
-
10:56
con: the role of currently available biomarkers genomics in risk stratification of prostate cancer
-
11:03
biomarkers for prostate cancer: whom to treat
-
11:49
updates in prostate cancer biomarkers
-
7:11
genetics and biomarkers for prostate cancer and bladder cancer
-
10:13
the role of genetic testing in prostate cancer
-
56:29
prostate cancer biomarkers and their role in the mri era | urology grand rounds
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
13:25
progess in understanding pathology of prostate cancer
-
21:20
next generation sequencing of prostate tumors: use of individualized biomarkers
-
13:24
genetics and genomic biomarkers: how molecular markers and mpmri play a role
-
16:25
forward progress in molecular markers in prostate cancer
-
20:50
active surveillance 2021 - from bench to bedside
-
19:46
biomarkers: a way forward with prostate cancer early detection
-
24:54
panel discussion - next generation genomics and prostate cancer biomarkers
-
15:45
current and emerging role of radiogenomics in risk assessment for prostate cancer
-
6:18
updates of changes in the early detection of prostate cancer nccn guidelines 2021
-
10:51
advanced prostate cancer clinical trials update 2022
-
46:19
webinar - beyond psa: the exodx prostate™ test (epi) as a precision genomic biomarker